Front Endocrinol (Lausanne) 12721135
In the new study, Intermountain researchers found that GLP1RAs dont increase the risk of pancreatitis in these patients and for those who have never had pancreatitis, being on a GLP1RA medication led to a four times lower risk of developing the condition
Hunt K, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG , Clayman G, Hung MC
81 In a subsequent analysis of these study data, the same researchers found that subjects with at least a 25% reduction in symptoms exhibited a significantly greater decrease in the ratio of omega-6s to omega-3s in their blood at three and six months
Enzymatic defect in Fabrys disease: ceramidetrihexosidase deficiency
Precaution: A twice-yearly full body skin examination is recommended for patients using the approved brand Scenesse, as there is an ongoing concern that increased melanocyte proliferation may elevate the risk of atypical moles or melanoma in susceptible individuals